Jérémie Prévost

5.5k total citations
57 papers, 1.2k citations indexed

About

Jérémie Prévost is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jérémie Prévost has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Virology, 30 papers in Infectious Diseases and 28 papers in Immunology. Recurrent topics in Jérémie Prévost's work include HIV Research and Treatment (36 papers), Immune Cell Function and Interaction (23 papers) and HIV/AIDS drug development and treatment (15 papers). Jérémie Prévost is often cited by papers focused on HIV Research and Treatment (36 papers), Immune Cell Function and Interaction (23 papers) and HIV/AIDS drug development and treatment (15 papers). Jérémie Prévost collaborates with scholars based in Canada, United States and Germany. Jérémie Prévost's co-authors include Andrés Finzi, Jonathan Richard, Shilei Ding, Halima Medjahed, Daniel E. Kaufmann, Andrés Finzi, Marzena Pazgier, Guillaume Beaudoin-Bussières, Nirmin Alsahafi and Romain Gasser and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jérémie Prévost

54 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérémie Prévost Canada 22 684 660 522 193 190 57 1.2k
Claudia Pastori Italy 16 602 0.9× 384 0.6× 416 0.8× 177 0.9× 104 0.5× 35 912
Cecilia Cabrera Spain 21 1.0k 1.5× 669 1.0× 750 1.4× 337 1.7× 63 0.3× 65 1.7k
Jocelyn T. Kim United States 12 379 0.6× 296 0.4× 330 0.6× 99 0.5× 54 0.3× 24 892
Ai Kawana‐Tachikawa Japan 19 539 0.8× 365 0.6× 528 1.0× 179 0.9× 54 0.3× 63 1.1k
Víctor Ramos United States 12 294 0.4× 453 0.7× 316 0.6× 106 0.5× 44 0.2× 21 805
Marlén M. I. Aasa-Chapman United Kingdom 15 584 0.9× 307 0.5× 433 0.8× 131 0.7× 191 1.0× 21 878
Bianca Schulte Germany 14 306 0.4× 412 0.6× 181 0.3× 115 0.6× 39 0.2× 25 792
Marion F. Gruber United States 18 204 0.3× 266 0.4× 346 0.7× 258 1.3× 72 0.4× 37 901
Matthew S. Parsons Australia 25 878 1.3× 290 0.4× 1.1k 2.0× 315 1.6× 341 1.8× 61 1.4k
Pierre Pellegrino United Kingdom 14 485 0.7× 193 0.3× 528 1.0× 165 0.9× 42 0.2× 20 859

Countries citing papers authored by Jérémie Prévost

Since Specialization
Citations

This map shows the geographic impact of Jérémie Prévost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérémie Prévost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérémie Prévost more than expected).

Fields of papers citing papers by Jérémie Prévost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérémie Prévost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérémie Prévost. The network helps show where Jérémie Prévost may publish in the future.

Co-authorship network of co-authors of Jérémie Prévost

This figure shows the co-authorship network connecting the top 25 collaborators of Jérémie Prévost. A scholar is included among the top collaborators of Jérémie Prévost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérémie Prévost. Jérémie Prévost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tauzin, Alexandra, Jérémie Prévost, Halima Medjahed, et al.. (2025). The HIV-1 envelope cytoplasmic tail protects infected cells from ADCC by downregulating CD4. mBio. 16(10). e0176325–e0176325. 1 indexed citations
2.
Chatterjee, Debashree, Ling Niu, Halima Medjahed, et al.. (2025). A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120. Journal of Virology. 99(4). e0226724–e0226724.
3.
Prévost, Jérémie, Nikesh Tailor, Geoff Soule, et al.. (2025). CD4+ and CD8+ T cells are not the main driver of Lassa fever pathogenesis in macaques. JCI Insight. 10(22).
4.
Richard, Jonathan, Gérémy Sannier, Jérémie Prévost, et al.. (2024). CD4 downregulation precedes Env expression and protects HIV-1-infected cells from ADCC mediated by non-neutralizing antibodies. mBio. 15(11). e0182724–e0182724. 2 indexed citations
5.
Grunst, Michael W., Zhuan Qin, Shilei Ding, et al.. (2024). Structure and inhibition of SARS-CoV-2 spike refolding in membranes. Science. 385(6710). 757–765. 20 indexed citations
6.
Prévost, Jérémie, Angela Sloan, Yvon Deschambault, et al.. (2024). Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates. Antiviral Research. 231. 105995–105995. 17 indexed citations
7.
Laumaea, Annemarie, Lorie Marchitto, Shilei Ding, et al.. (2023). Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity. Cell Reports. 42(1). 111983–111983. 11 indexed citations
8.
Richard, Jonathan, Jérémie Prévost, Catherine Bourassa, et al.. (2023). Temsavir blocks the immunomodulatory activities of HIV-1 soluble gp120. Cell chemical biology. 30(5). 540–552.e6. 12 indexed citations
9.
Prévost, Jérémie, Jonathan Richard, Romain Gasser, et al.. (2022). Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4 + T Cell. Journal of Virology. 96(6). e0192921–e0192921. 8 indexed citations
10.
Gong, Shang Yu, Shilei Ding, Mehdi Benlarbi, et al.. (2022). Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2. Viruses. 14(10). 2178–2178. 9 indexed citations
11.
Papenburg, Jesse, Matthew P. Cheng, Rachel Corsini, et al.. (2021). Evaluation of a Commercial Culture-Free Neutralization Antibody Detection Kit for Severe Acute Respiratory Syndrome-Related Coronavirus-2 and Comparison With an Antireceptor-Binding Domain Enzyme-Linked Immunosorbent Assay. Open Forum Infectious Diseases. 8(6). ofab220–ofab220. 27 indexed citations
12.
Gong, Shang Yu, Debashree Chatterjee, Jonathan Richard, et al.. (2021). Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity. Virology. 563. 134–145. 47 indexed citations
13.
Beaudoin-Bussières, Guillaume, Jonathan Richard, Jérémie Prévost, Guillaume Goyette, & Andrés Finzi. (2021). A new flow cytometry assay to measure antibody-dependent cellular cytotoxicity against SARS-CoV-2 Spike-expressing cells. STAR Protocols. 2(4). 100851–100851. 23 indexed citations
14.
Anand, Sai Priya, Jérémie Prévost, Jonathan Richard, et al.. (2021). High‐throughput detection of antibodies targeting the SARS‐CoV ‐2 Spike in longitudinal convalescent plasma samples. Transfusion. 61(5). 1377–1382. 13 indexed citations
15.
Prévost, Jérémie & Andrés Finzi. (2021). The great escape? SARS-CoV-2 variants evading neutralizing responses. Cell Host & Microbe. 29(3). 322–324. 41 indexed citations
16.
Jacob, Rajesh Abraham, Jérémie Prévost, Frank Kirchhoff, et al.. (2021). The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor Tim-3 in infected CD4+ T cells. Journal of Biological Chemistry. 297(3). 101042–101042. 14 indexed citations
17.
Lewin, Antoine, Gaston De Serres, Yves Grégoire, et al.. (2021). SARS-CoV-2 seroprevalence among blood donors in Québec, and analysis of symptoms associated with seropositivity: a nested case-control study. Canadian Journal of Public Health. 112(4). 576–586. 18 indexed citations
18.
Alsahafi, Nirmin, Jonathan Richard, Jérémie Prévost, et al.. (2017). Impaired Downregulation of NKG2D Ligands by Nef Proteins from Elite Controllers Sensitizes HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity. Journal of Virology. 91(16). 27 indexed citations
19.
Levast, Benoît, Mathieu Coutu, Jérémie Prévost, et al.. (2017). HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes. PLoS ONE. 12(3). e0174550–e0174550. 14 indexed citations
20.
Richard, Jonathan, Jérémie Prévost, Nirmin Alsahafi, Shilei Ding, & Andrés Finzi. (2017). Impact of HIV-1 Envelope Conformation on ADCC Responses. Trends in Microbiology. 26(4). 253–265. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Pastori Breakdown of academic impact, for papers by Cecilia Cabrera Breakdown of academic impact, for papers by Jocelyn T. Kim Breakdown of academic impact, for papers by Ai Kawana‐Tachikawa Breakdown of academic impact, for papers by Víctor Ramos Breakdown of academic impact, for papers by Marlén M. I. Aasa-Chapman Breakdown of academic impact, for papers by Bianca Schulte Breakdown of academic impact, for papers by Marion F. Gruber Breakdown of academic impact, for papers by Matthew S. Parsons Breakdown of academic impact, for papers by Pierre Pellegrino
Rankless by CCL
2026